Salivary Cortisol Levels in Persons With and Without Different Anxiety Disorders
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the association between several subtypes of anxiety disorders and various cortisol indicators in a large cohort study. Anxiety disorders have been suggested to be linked to hypothalamic-pituitary-adrenal (HPA) axis activity, although results are scarce and inconsistent. No earlier studies have examined consistency of HPA axis findings across several anxiety subtypes and whether associations are state or trait dependent. METHODS: Data are derived from 1427 participants of the Netherlands Study of Depression and Anxiety. Three groups were compared: 342 control participants without psychiatric disorders; 311 persons with a remitted (no current) anxiety disorder (social phobia, generalized anxiety disorder, panic disorder); and 774 persons with a current anxiety disorder, as diagnosed using the Composite International Diagnostic Interview psychiatric interview. Cortisol levels were measured in seven saliva samples, determining the 1-hour cortisol awakening response, evening cortisol, and cortisol response after 0.5 mg of dexamethasone ingestion. RESULTS: Current anxiety disorder was associated with higher awakening cortisol levels (p = .002). These findings were mainly present for patients with panic disorder with agoraphobia and anxious patients with comorbid depressive disorder. Remitted anxiety only showed a trend toward higher morning cortisol (p = .08). No associations were observed for anxiety status and evening cortisol level or cortisol suppression after dexamethasone. CONCLUSIONS: This study showed a modest but significantly higher 1-hour cortisol awakening response among anxiety patients, which was driven by those with panic disorder with agoraphobia and those with comorbid depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Higher cortisol awaking response has been described in individuals with PD with agoraphobia (Vreeburg et al, 2010)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vreeburg et al, 2010
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619 · cited 1×
“in 1000 MET-minutes (metabolic energy turnover per minute) a week (34).”
BackgroundAn inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407 · cited 8×
“severity, the 21-item BAI (35) was used.”
InfluentialStress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621 · cited 1×
“A nxiety disorders can be precipitated and accompanied by stress (1) and may, therefore, be associated with hypothalamic-pituitary-adrenal (HPA) axis dysregulation (2).”
BackgroundPruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00108-7 · Cited by 3,638 · cited 1×
“to the ground (AUCg), using Pruessner’s formulas (31).”
MethodCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243 · cited 1×
“This test provides information on the negative feedback system of the HPA axis, because dexamethasone reduces cortisol level by acting on the pituitary (33).”
BackgroundSalivary cortisol as a biomarker in stress research
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.10.026 · Cited by 1,925
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801 · cited 1×
“the 15-item Fear Questionnaire was used (36).”
Salivary Cortisol in Psychobiological Research: An Overview
Kirschbaum, C., & Hellhammer, D. H. (2008) · Neuropsychobiology · doi:10.1159/000118611 · Cited by 1,532 · cited 1×
“saliva sampling, reflecting the active unbound form of cortisol (28).”
BackgroundGueorguieva, R., & Krystal, J. H. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.310 · Cited by 1,529 · cited 2×
“take correlation between repeated data into account (32).”
BackgroundThe role of corticotropin-releasing factor in depression and anxiety disorders
Arborelius, L., Owens, M., Plotsky, P., & Nemeroff, C. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600001 · Cited by 1,378 · cited 1×
“Anxiety disorder has—although inconsistently—been linked to increased corticotropin-releasing factor, which stimulates HPA axis activity (6).”
BackgroundThe cortisol awakening response (CAR): Facts and future directions
Fries, E., Dettenborn, L., & Kirschbaum, C. (2009) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2008.03.014 · Cited by 1,188 · cited 1×
“The CAR is a response to awakening (37) and has been hypothesized to be associated with activation of prospective memory representations at awakening, enabling orientation in time and space and anticipation of the upcoming day (38).”
BackgroundThe Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods
Penninx, B. W. J. H., Beekman, A. T. F., Smit, J. H., Zitman, F. G., Nolen, W. A., Spinhoven, P., Cuijpers, P., De Jong, P. J., Van Marwijk, H. W. J., Assendelft, W. J. J., et al. (2008) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.256 · Cited by 927 · cited 1×
“Objectives and methods of NESDA are described in the study by Penninx and colleagues (27).”
MethodSelf-citationMajor depressive disorder and hypothalamic-pituitary-adrenal axis activity
Vreeburg, S. A., Hoogendijk, W. J. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.50 · Cited by 792 · cited 5×
“25) and comparable to the effect size previously described for MDD (26).”
BackgroundResultSelf-citation(2005) · PubMed · Cited by 470
Is the cortisol awakening rise a response to awakening?
Wilhelm, I., Born, J., Kudielka, B. M., Schlotz, W., & Wüst, S. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.01.008 · Cited by 454
Strine, T. W., Mokdad, A. H., Balluz, L. S., Gonzalez, O., Crider, R. A., Berry, J. T., & Kroenke, K. (2008) · Psychiatric Services · doi:10.1176/appi.ps.59.12.1383 · Cited by 408 · cited 2×
“Moreover, the somatic consequences of anxiety disorders, such as the higher prevalence of cardiovascular disease and diabetes (5), may point to HPA axis dysregulation.”
BackgroundYoung, E. A., Abelson, J. L., & Cameron, O. G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.017 · Cited by 229 · cited 1×
“(44) also found that social phobia was SALIVARY CORTISOL LEVELS IN ANXIETY DISORDERS”
BackgroundMantella, R. C., Butters, M. A., Amico, J. A., Mazumdar, S., Rollman, B. L., Begley, A. E., Reynolds, C. F., & Lenze, E. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.002 · Cited by 222 · cited 3×
“Only few studies have examined HPA axis activity in generalized anxiety disorder (GAD), illustrating elevated (17) or normal basal cortisol levels (18–20) and more nonsuppression (14) or normal suppression (21,22) after dexamethasone.”
BackgroundResultde Graaf, R., Bijl, R. V., Spijker, J., Beekman, A. T. F., & Vollebergh, W. A. M. (2003) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-003-0597-4 · Cited by 203 · cited 1×
“Comorbidity between MDD and anxiety is highly frequent (5,25), and MDD has shown to be associated with elevated cortisol levels by our group (26) and others.”
BackgroundVreeburg, S. A., Kruijtzer, B. P., van Pelt, J., van Dyck, R., DeRijk, R. H., Hoogendijk, W. J. G., Smit, J. H., Zitman, F. G., & Penninx, B. W. J. H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.04.024 · Cited by 193
Self-citationDockray, S., Bhattacharyya, M. R., Molloy, G. J., & Steptoe, A. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.10.001 · Cited by 180 · cited 1×
“However, even when awakening is closely monitored, still at least 15% of all persons did not respond with a cortisol increase (45).”
BackgroundSalivary Cortisol Is Related to Atherosclerosis of Carotid Arteries
Dekker, M. J. H. J., Koper, J. W., van Aken, M. O., Pols, H. A. P., Hofman, A., de Jong, F. H., Kirschbaum, C., Witteman, J. C. M., Lamberts, S. W. J., & Tiemeier, H. W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0496 · Cited by 172 · cited 1×
“Although the clinical relevance of such differences needs to be explored in further large-scale research, there is some evidence that cortisol level may predict functional disability in panic patients (43) and is associated with unfavorable somatic outcomes, such as atherosclerotic plaques (48).”
BackgroundLife events and the onset of panic disorder
Roy‐Byrne, P., Geraci, M. F., & Uhde, T. W. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1424 · Cited by 155 · cited 1×
“A nxiety disorders can be precipitated and accompanied by stress (1) and may, therefore, be associated with hypothalamic-pituitary-adrenal (HPA) axis dysregulation (2).”
BackgroundNeuroendocrine Responses to Psychological Stress in Adolescents with Anxiety Disorder
Gerra, G., Zaimovic, A., Zambelli, U., Timpano, M., Reali, N., Bernasconi, S., & Brambilla, F. (2000) · Neuropsychobiology · doi:10.1159/000026677 · Cited by 153 · cited 15×
“Only few studies have examined HPA axis activity in generalized anxiety disorder (GAD), illustrating elevated (17) or normal basal cortisol levels (18–20) and more nonsuppression (14) or normal suppression (21,22) after dexamethasone.”
ResultInfluentialAbelson, J. L. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830040059010 · Cited by 141 · cited 1×
“Previous studies reported no difference in evening cortisol levels (10,17,18,24) as well as more pronounced HPA dysregulation during the night for anxiety disorders (7,9).”
BackgroundStahl, S. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0101 · Cited by 139
Dysregulation of the Hypothalamic-Pituitary-Adrenocortical System in Panic Disorder
Schreiber, W., Lauer, C. J., Krumrey, K., Holsboer, F., & Krieg, J. C. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00146-5 · Cited by 123 · cited 1×
“Alternatively, perhaps differences in the negative feedback system of the HPA axis become more pronounced when using the more sensitive dexamethasone-corticotropin-releasing hormone test (39,40).”
BackgroundRegulation of the Hypothalamic–Pituitary–Adrenocortical System in Patients with Panic Disorder
Erhardt, A., Ising, M., Unschuld, P. G., Kern, N., Lucae, S., Pütz, B., Uhr, M., Binder, E. B., Holsboer, F., & Keck, M. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301168 · Cited by 116
Salivary Cortisol Response During Exposure Treatment in Driving Phobics
Alpers, G. W., Abelson, J. L., Wilhelm, F. H., & Roth, W. T. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000073872.85623.0c · Cited by 100 · cited 1×
“Third, our study did not include specific phobias that have been associated with especially cortisol elevations during acute anxiety (46).”
BackgroundGarcia-Leal, C., Parente, A. C. B. V., Del‐Ben, C. M., Guimarães, F. S., Moreira, A. C., Elias, L. L. K., & Graeff, F. G. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.010 · Cited by 97 · cited 2×
“No difference between symptomatic and nonsymptomatic panic disorder in basal cortisol level was reported by Garcia-Leal and colleagues (10).”
BackgroundChaudieu, I., Beluche, I., Norton, J. L., Boulenger, J., Ritchie, K. A., & Ancelin, M. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.07.025 · Cited by 96 · cited 16×
“Only few studies have examined HPA axis activity in generalized anxiety disorder (GAD), illustrating elevated (17) or normal basal cortisol levels (18–20) and more nonsuppression (14) or normal suppression (21,22) after dexamethasone.”
BackgroundResultInfluentialElevated alpha-amylase but not cortisol in generalized social anxiety disorder
van Veen, J. F., van Vliet, I. M., DeRijk, R. H., van Pelt, J., Mertens, B., & Zitman, F. G. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.004 · Cited by 88 · cited 5×
“Regarding social phobia, most studies described no difference in basal cortisol level (23,24).”
BackgroundResultSelf-citationDoes the panic attack activate the hypothalamic-pituitary-adrenal axis?
Graeff, F. G., Garcia-Leal, C., Del‐Ben, C. M., & Guimarães, F. S. (2005) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652005000300009 · Cited by 86 · cited 1×
“However, literature that does exist on cortisol levels during panic attacks, for instance, points more to the direction of an effect of anticipatory anxiety than acute effects (47).”
BackgroundPsychoimmunoendocrine Aspects of Panic Disorder
Brambilla, F., Bellodi, L., Ferna, G., Battaglia, M., Sciuto, G., Diaferia, G., Petraglia, F., Panerai, A. E., & Sacerdote, P. (2008) · Neuropsychobiology · doi:10.1159/000118890 · Cited by 78 · cited 1×
“For panic disorder (PD), some studies (7–10) have found higher basal cortisol levels, whereas others (11,12) have found no difference.”
BackgroundThe hypothalamic-pituitary-adrenal system in panic disorder
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.10.1320 · Cited by 75 · cited 2×
“In addition, studies showed normal suppression (13,14) or more nonsuppression after dexamethasone ingestion in PD (15,16).”
BackgroundResultDiurnal variation of cortisol in panic disorder
Bandelow, B., Wedekind, D., Sandvoss, V., Broocks, A., Hajak, G., Pauls, J., Peter, H., & Rüther, E. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00183-9 · Cited by 57 · cited 2×
“Studies that compared PD and PDA generated divergent results—either showing higher (8) or similar (9,39) basal cortisol levels among PDA.”
Kathol, R. G., Noyes, R., Lopez, A. L., & Reich, J. H. (1988) · Psychiatry Research · doi:10.1016/0165-1781(88)90064-9 · Cited by 45 · cited 2×
“(8) only found significantly higher levels of urinary cortisol for PD when accompanied by agoraphobia or comorbid MDD, compared with controls.”
BackgroundResultA 15-year follow-up study of patients with panic disorder
Andersch, S., & Hetta, J. (2003) · European Psychiatry · doi:10.1016/j.eurpsy.2003.03.007 · Cited by 45 · cited 1×
“Comorbidity of agoraphobia can be regarded as a severity indicator of PD, since it causes more severe disturbance (41) and predicts poor outcome (42).”
BackgroundThe Dexamethasone Suppression Test in Generalised Anxiety Disorder
Schweizer, E. E., Swenson, C. M., Winokur, A., Rickels, K., & Maislin, G. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.3.320 · Cited by 43 · cited 2×
“Only few studies have examined HPA axis activity in generalized anxiety disorder (GAD), illustrating elevated (17) or normal basal cortisol levels (18–20) and more nonsuppression (14) or normal suppression (21,22) after dexamethasone.”
BackgroundResultThe dexamethasone suppression test and plasma dexamethasone in generalized anxiety disorder
Tiller, J. W. G., Biddle, N., Maguire, K. P., & Davies, B. M. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90037-6 · Cited by 42 · cited 2×
“Only few studies have examined HPA axis activity in generalized anxiety disorder (GAD), illustrating elevated (17) or normal basal cortisol levels (18–20) and more nonsuppression (14) or normal suppression (21,22) after dexamethasone.”
BackgroundResult(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.1.69 · Cited by 40 · cited 2×
“leading to more avoidance and functional disability (43).”
BackgroundUrinary free cortisol levels in anxiety
Rosenbaum, A. H., Schatzberg, A. F., Jost, F. A., Cross, P. D., Wells, L. A., Jiang, N., & Maruta, T. (1983) · Psychosomatics · doi:10.1016/s0033-3182(83)73157-9 · Cited by 39
Cortisol response during different anxiogenic challenges in panic disorder patients
Targum, S. D. (1992) · Psychoneuroendocrinology · doi:10.1016/0306-4530(92)90003-p · Cited by 37 · cited 1×
“For panic disorder (PD), some studies (7–10) have found higher basal cortisol levels, whereas others (11,12) have found no difference.”
BackgroundComorbidity and its effects on panic disorder.
Маршалл (1996) · PubMed · Cited by 35
Dexamethasone suppression test in patients with panic attacks
Bridges, M., Yeragani, V. K., Rainey, J. M., & Pohl, R. B. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90254-4 · Cited by 32 · cited 2×
“In addition, studies showed normal suppression (13,14) or more nonsuppression after dexamethasone ingestion in PD (15,16).”
BackgroundResultPanic Disorder: An Overlapping or Independent Entity?
Okasha, A., Bishry, Z., Khalil, A. H., Darwish, T. A., El Dawla, A. S., & Shohdy, A. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.818 · Cited by 32
Westberg, P., Modigh, K., Lisjo, P. I., & Eriksson, E. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90109-y · Cited by 22 · cited 2×
“In addition, studies showed normal suppression (13,14) or more nonsuppression after dexamethasone ingestion in PD (15,16).”
BackgroundResultInvolvement of GABAA receptor modulating neuroactive steroids in patients with social phobia
Laufer, N., Maayan, R., Hermesh, H., Marom, S., Gilad, R., Strous, R. D., & Weizman, A. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.07.003 · Cited by 16 · cited 2×
“Regarding social phobia, most studies described no difference in basal cortisol level (23,24).”
BackgroundResultKessler, R. C., & Wïttchen, H. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.0065-1591.2000.acp29-01.x · Cited by 8
Cited by
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“Higher cortisol awaking response has been described in individuals with PD with agoraphobia (Vreeburg et al, 2010) and cortisol nonsuppression in response to dexamethasone in those with agoraphobia and PD (Coryell et al, 1989).”
BackgroundReview on Psychological Stress Detection Using Biosignals
Giannakakis, G., Grigoriadis, D., Giannakaki, K., Simantiraki, O., Roniotis, A., & Tsiknakis, M. (2022) · IEEE Transactions on Affective Computing · doi:10.1109/taffc.2019.2927337 · Cited by 764
“The characteristic early morning peak is internally driven occurring prior to awakening with a further increase triggered by exposure to psychological stress in response to awakening [12].”
BackgroundHair cortisol, stress exposure, and mental health in humans: A systematic review
Staufenbiel, S. M., Penninx, B. W. J. H., Spijker, A. T., Elzinga, B. M., & van Rossum, E. F. C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.11.015 · Cited by 736
Self-citationBasomedial amygdala mediates top-down control of anxiety and fear
Adhikari, A., Lerner, T. N., Finkelstein, J., Pak, S., Jennings, J. H., Davidson, T. J., Ferenczi, E., Gunaydin, L. A., Mirzabekov, J. J., Ye, L., et al. (2015) · Nature · doi:10.1038/nature15698 · Cited by 485
Anxiety and new onset of cardiovascular disease: critical review and meta-analysis
Batelaan, N. M., Seldenrijk, A., Bot, M., van Balkom, A. J. L. M., & Penninx, B. W. J. H. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.156554 · Cited by 362
Self-citation
Metadata
- Authors
- Vreeburg, S. A., Zitman, F. G., van Pelt, J., DeRijk, R. H., Verhagen, J. C. M., van Dyck, R., Hoogendijk, W. J. G., Smit, J. H., & Penninx, B. W. J. H.
- Affiliations
- Amsterdam Public Health (NL)
- University Medical Center Groningen (NL)
- Corresponding author
- Vreeburg, Sophie A.
- Venue
- Psychosomatic Medicine
- Published
- 2010-05
- Volume
- 72
- Issue
- 4
- Pages
- 340-347
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2096838333
- Cited by
- 312
- References
- 49
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 18 · 2023: 20 · 2022: 19 · 2021: 15 · 2020: 17 · 2019: 23 · 2018: 21 · 2017: 23 · 2016: 19 · 2015: 24 · 2014: 25 · 2013: 23 · 2012: 22
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- VU Research Portal (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- anxiety disorders, salivary cortisol, cortisol awakening response, hypothalamic-pituitary-adrenal axis, panic disorder with agoraphobia, generalized anxiety disorder, social anxiety disorder, dexamethasone suppression, comorbid depression
- MeSH terms
- Adult, Agoraphobia, Anxiety Disorders, Circadian Rhythm, Major Depressive Disorder, Female, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Male, Middle Aged, Personality Inventory, Phobic Disorders, Pituitary-Adrenal System, Saliva, Seasons, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.